SEC Form SC 13D/A filed by Amneal Pharmaceuticals Inc. (Amendment)

Item 2 of the Schedule 13D is hereby deleted in its entirety and replaced with the following:

The Schedule 13D is being filed by Gautam Patel (the “Reporting Person”).

The present principal occupation of the Reporting Person is serving as President of Cepheid Capital, LLC.  Prior to January 1, 2024, the Reporting Person also served as President of Tattva Fiduciary Company (“Tattva”) and was the sole owner of Tattva.

The T-Twelve Legacy Trust dated December 8, 2006 (the “T-Twelve Trust”) is an irrevocable trust governed by the laws of the State of Nevada, of which Tattva is the sole trustee.

The Falcon Trust dated December 11, 2001 (the “Falcon Trust”) is an irrevocable trust governed by the laws of the State of Nevada, of which Tattva is the sole trustee.

The AHPPCB Legacy Trust U/A February 1, 2014 (the “Legacy Trust” and, together with the T-Twelve Trust and the Falcon Trust, the “Trusts”) is an irrevocable trust governed by the laws of the State of Nevada, of which Tattva is the sole trustee.  Tattva is also the sole trustee of certain other trusts that hold Class A Common Stock of the New Issuer.

The business address of the Reporting Person is 1 John Street, #9D, Brooklyn, NY 11201.

The business address of each of the Trusts is c/o Sierra Fiduciary Support Services, 100 West Liberty Way, 10th Floor, Reno, Nevada 89501.

During the last five years, the Reporting Person has not been (i) convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

The disclosure in Item 4 is hereby amended and supplemented by adding the following:

On January 1, 2024, the Reporting Person entered into a Stock Purchase and Sale Agreement with Akram Mahesh (“Mahesh”), pursuant to which the Reporting Person sold to Mahesh 1,000 shares of the common stock of Tattva, which constitute all of the issued and outstanding common stock of Tattva (the “Sale Transaction”).  In connection with the Sale Transaction, the Reporting Person also resigned from his positions as Director, President, Discretionary Committee Member and Investment Committee Member of Tattva, effective as of January 1, 2024 (the “Resignation”).  As a result of the Sale Transaction and the Resignation, the Reporting Person no longer has sole or shared voting or dispositive power over, or deemed beneficial ownership of, any of the shares of Class A Common Stock of the New Issuer held by any trusts (including the Trusts) of which Tattva is the sole trustee.

The Reporting Person is a beneficiary of the Legacy Trust.  Following the effectiveness of the Sale Transaction and the Resignation, on January 1, 2024, the Reporting Person received a distribution of 1,598,115 shares of Class A Common Stock of the New Issuer from the Legacy Trust.

Reporting Person		Amount beneficially owned				Percent of class				Sole power to vote or to direct the vote				Shared power to vote or to direct the vote				Sole power to dispose or to direct the disposition				Shared power to dispose or to direct the disposition
Gautam Patel			2,025,454				0.07				2,025,454				0				2,025,454				0

(c)	The information set forth in Item 4 of this Amendment No. 5 is incorporated by reference herein.

(d)

None.

(e)	January 1, 2024.

SIGNATURES

Date: January 3, 2024